BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4468627)

  • 21. [The effect of prednisolone on the blood coagulation system in chronic hepatitis].
    Krutovskaia OV
    Klin Med (Mosk); 1967 Aug; 45(8):70-3. PubMed ID: 5610475
    [No Abstract]   [Full Text] [Related]  

  • 22. [The value of investigation of amino acid composition of the blood plasma on the amino acid analyzer in chronic diseases of the liver].
    Loginov AC; Isakova ZS
    Ter Arkh; 1973 Apr; 45(4):104-8. PubMed ID: 4723354
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum leptin levels in patients with nonalcoholic chronic liver disease.
    Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
    Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiocopper (64Cu) incorporation into ceruloplasmin in chronic active hepatitis and in liver cirrhosis.
    Piaggi V; Zeneroli ML; Rocchi E; Gibertini P; Cremonini C; Gozzi MG; Ventura E
    J Nucl Med Allied Sci; 1980; 24(3-4):177-81. PubMed ID: 7252581
    [No Abstract]   [Full Text] [Related]  

  • 25. [Dynamics of concentration of insulin and growth hormone in blood serum in chronic liver diseases].
    Shlimovich PB; Sokolov IaA; Moskvichev AM
    Klin Med (Mosk); 1976 Jun; 54(6):90-5. PubMed ID: 972523
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma fibrin stabilising factor (F.S.F.) activity in normal subjects and patients with chronic liver disease.
    Walls WD; Losowsky MS
    Thromb Diath Haemorrh; 1969 Feb; 21(1):134-43. PubMed ID: 5773724
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical significance of haptoglobin in chronic hepatitis and liver cirrhosis of viral etiology].
    Denisenko LN
    Ter Arkh; 1971 Oct; 43(10):38-41. PubMed ID: 5140948
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Contribution on the therapy of chronic liver parenchymal damage with 6-mercaptopurine].
    Mott R; Knief J; Faul J
    Med Klin; 1968 Sep; 63(36):1422-8. PubMed ID: 5729432
    [No Abstract]   [Full Text] [Related]  

  • 30. [Proceedings: Determination of total blood estrogen in liver cirrhosis and chronic hepatitis].
    Sakuma M; Takatori E; Shizume K; Osawa N
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):320. PubMed ID: 4476430
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study of total insulin activity and the content of free insulin in the blood in chronic diffuse liver diseases].
    Rostomova LT; Kurashvili RB
    Ter Arkh; 1974; 46(12):87-90. PubMed ID: 4454029
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pathological changes in serum bile acids in acute and chronic hepatitis].
    Cimino T; Spezia C; Marietti G
    Arch Sci Med (Torino); 1980; 137(3):471-5. PubMed ID: 7235935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anemic syndrome in chronic hepatitis and liver cirrhosis].
    Korolko IuR; Sarycheva TG; Kotelńikov VM; Kozinets GI; Zherebtsov LA
    Klin Med (Mosk); 1993; 71(5):45-8. PubMed ID: 8301986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Indices of phagocytic activity of leukocytes and leukocyte glycogen content in liver diseases].
    Epishin AV; Epishina NA; Dobrodzii GN
    Vrach Delo; 1978 May; (5):92-6. PubMed ID: 676286
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bile acids in acute hepatitis and in hepatitis with a chronic course].
    de la Vega Vázquez JM; Vahí Serrano S; Holgado Silva C; Sánchez Burgos R; Pineda Albornoz A; Aznar Martín A; Gómez Rodriquez F; Aznar Reig A
    Rev Clin Esp; 1982 Feb; 164(4):259-62. PubMed ID: 7089347
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes in the amino acid spectrum of blood in chronic liver diseases and their importance in developing specific preparations for parenteral protein nutrition].
    Petrova MP; Rogacheva NA; Miterev IuG; Zherebtsov LA; Vasil'ev PS
    Probl Gematol Pereliv Krovi; 1982 Aug; 27(8):45-9. PubMed ID: 6813848
    [No Abstract]   [Full Text] [Related]  

  • 37. Study on the correlation between Normotest, Quick's method, and specific coagulation factors in liver disease.
    Hadchouel P; Touboul JP; Caroli J
    Scand J Gastroenterol Suppl; 1973; 19():151-4. PubMed ID: 4515639
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study of plasma lipids in patients with liver cirrhosis and hepatitis].
    Platzer S; Sailer S; Sandhofer F; Braunsteiner H
    Wien Klin Wochenschr; 1966 Jan; 78(4):56-8. PubMed ID: 5962258
    [No Abstract]   [Full Text] [Related]  

  • 40. [Correlation between fibrinolysis and the indexes of blood coagulation and of hepatic damage in chronic liver disease and liver cirrhosis].
    Craveri A; Cerrini R; Repaci G; Saracino F
    G Clin Med; 1968 Dec; 49(12):1326-53. PubMed ID: 4242987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.